Autres langues Ganga Pharmaceuticals Limited

Actions

GANGAPHARM6

INE615T01017

Produits pharmaceutiques

Marché Fermé - Bombay S.E. 12:02:27 08/09/2026			Varia. 5j.	Varia. 1 janv.
12,50 ^INR	+4,17%		-.--%	+7,02%

21/05	Ganga Pharmaceuticals Limited publie ses résultats annuels pour l'exercice clos le 31 mars 2026	CI
10/03	Ganga Pharmaceuticals reconduit Bharat Brijmohan Sharma au poste de directeur général	RE

Autres langues

21/05	Ganga Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2026
10/03	Ganga Pharmaceuticals re-appoints Bharat Brijmohan Sharma as MD
07/11	Ganga Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended September 30, 2025
01/07/25	Ganga Pharmaceuticals Limited Appoints Priti Bhaiya as Company Secretary and Compliance Officer, Effective July 01, 2025
20/05/25	Ganga Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025
22/04/25	Ganga Pharmaceuticals Limited Announces Resignation of Priti Kothari Bhaiya, Company Secretary and Compliance Officer of the Company Effective, April 22, 2025
31/03/25	Ganga Pharmaceuticals Limited Announces Cessation of Chetan Bhikhubhai Patel and Sachin Chandrakant Chavan as Independent Directors and Member of the Board
08/11/24	Ganga Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended September 30, 2024
16/05/24	Ganga Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024
19/01/24	Ganga Pharmaceuticals Limited announced that it has received INR 17.0625 million in funding from Lenus Finvest Pvt Ltd, Plutus Capital Management Llp
04/12/23	Ganga Pharmaceuticals Limited announced that it expects to receive INR 21 million in funding from Lenus Finvest Pvt Ltd, Plutus Capital Management Llp
27/11/23	Ganga Pharmaceuticals Board to Consider Issuing Equity, Convertible Warrants to Raise Funds
08/11/23	Ganga Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended September 30, 2023
22/08/23	Ganga Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2023
11/11/22	Ganga Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended September 30, 2022
25/05/22	Ganga Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2022
28/06/21	Ganga Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2021
05/11/20	Ganga Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended September 30, 2020
27/06/20	Ganga Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020
25/05/20	Ganga Pharmaceuticals Limited Announces Management Changes
27/08/19	Ganga Pharmaceuticals Limited Announces the Appointment and Re-Designation of Sanjay Kulkarni as Executive Director
13/05/19	Ganga Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2019
23/02/19	874,550 equity shares of Ganga Pharmaceuticals Limited are subject to a Lock-Up Agreement Ending on 23-FEB-2019.
05/11/18	Ganga Pharmaceuticals Limited Reports Unaudited Standalone Earnings Results for the Half Year Ended September 30, 2018
06/09/18	Ganga Pharmaceuticals Limited Appoints Anagh B. Sharma as Chief Financial Officer